Doctors Note Logo

Published on: 2/28/2026

Worried by Empagliflozin? The Science & Medically Approved Next Steps

Empagliflozin is well studied and widely recommended for type 2 diabetes, some heart failure, and chronic kidney disease, with proven heart and kidney protection and modest improvements in A1C, weight, and blood pressure.

Rare but serious risks like euglycemic ketoacidosis, dehydration or low blood pressure, and severe genital infections mean you should follow medically approved steps such as staying hydrated, smart monitoring, knowing sick-day pauses, and when to seek urgent care, all outlined below. There are several factors to consider; see details below to understand more.

answer background

Explanation

Worried About Empagliflozin? The Science & Medically Approved Next Steps

If you've been prescribed empagliflozin and feel concerned about taking it, you're not alone. It's normal to have questions about any medication—especially one used to treat conditions like type 2 diabetes, heart failure, or chronic kidney disease.

The good news? Empagliflozin is well studied, widely used, and backed by strong clinical evidence. But like any medication, it has benefits, risks, and important safety considerations. Let's walk through what the science says and what you should do next.


What Is Empagliflozin?

Empagliflozin (brand name commonly known as Jardiance) is a prescription medication used to:

  • Lower blood sugar in adults with type 2 diabetes
  • Reduce the risk of cardiovascular death in adults with type 2 diabetes and heart disease
  • Treat certain types of heart failure
  • Slow progression of chronic kidney disease in some patients

It belongs to a class of drugs called SGLT2 inhibitors (sodium-glucose co-transporter 2 inhibitors).

How It Works

Empagliflozin works through your kidneys. It:

  • Blocks a protein that reabsorbs glucose into the bloodstream
  • Causes excess glucose to be removed through urine
  • Helps lower blood sugar levels
  • Reduces strain on the heart and kidneys

This mechanism is different from insulin or many older diabetes medications.


Why Doctors Prescribe Empagliflozin

Large clinical trials have shown that empagliflozin provides meaningful benefits beyond blood sugar control.

Proven Benefits

According to major clinical trials such as EMPA-REG OUTCOME and EMPEROR trials, empagliflozin can:

  • ✅ Lower A1C (average blood sugar levels)
  • ✅ Reduce the risk of cardiovascular death
  • ✅ Decrease hospitalization for heart failure
  • ✅ Slow progression of kidney disease
  • ✅ Support modest weight loss
  • ✅ Slightly reduce blood pressure

These benefits are why many medical guidelines now recommend empagliflozin early in treatment—especially for patients with heart or kidney risks.


Common Side Effects of Empagliflozin

Most people tolerate empagliflozin well. However, side effects can happen.

Common (Usually Mild)

  • Increased urination
  • Genital yeast infections
  • Urinary tract infections
  • Mild dehydration
  • Dizziness (especially when standing)

These occur because the medication increases glucose in urine, which can promote infections and fluid loss.

Staying hydrated and practicing good hygiene can reduce risk.


Serious But Rare Risks

It's important not to ignore the more serious risks—but also not to panic. They are uncommon, especially when monitored appropriately.

1. Diabetic Ketoacidosis (DKA)

Empagliflozin can, in rare cases, cause euglycemic diabetic ketoacidosis—a serious condition where the body produces too many ketones even if blood sugar is not extremely high.

Seek urgent medical care if you have:

  • Nausea or vomiting
  • Severe fatigue
  • Abdominal pain
  • Rapid breathing
  • Confusion

This is uncommon but potentially life-threatening.


2. Severe Dehydration or Low Blood Pressure

Higher urination can lead to:

  • Lightheadedness
  • Fainting
  • Weakness

This risk is higher if you:

  • Are over 65
  • Take diuretics ("water pills")
  • Have kidney disease

3. Kidney Function Changes

Empagliflozin may cause a small, temporary drop in kidney function when starting the medication. In most cases, this stabilizes and provides long-term protection.

Your doctor will monitor kidney labs.


4. Fournier's Gangrene (Extremely Rare)

A rare but serious infection of the genital area has been reported with SGLT2 inhibitors.

It is very uncommon. Seek urgent care for:

  • Severe genital pain
  • Swelling
  • Fever

Again, this is rare—but serious.


When Worry Is Appropriate

You should speak to a doctor immediately if you experience:

  • Signs of ketoacidosis
  • Severe weakness or fainting
  • Persistent vomiting
  • Severe genital pain or swelling
  • Chest pain
  • Severe shortness of breath

These may signal something serious or life-threatening.

If symptoms feel urgent or severe, do not wait—seek emergency care.


When Worry Is Not Necessary

Many concerns about empagliflozin stem from reading long side-effect lists. It's important to understand:

  • Most patients tolerate it well
  • Serious side effects are uncommon
  • Benefits often outweigh risks in appropriate patients
  • Monitoring greatly reduces risk

Your prescribing provider considered your health profile before recommending this medication.


Who Should Not Take Empagliflozin?

Empagliflozin may not be appropriate if you:

  • Have type 1 diabetes (higher DKA risk)
  • Have severe kidney failure
  • Are prone to frequent ketoacidosis
  • Are severely dehydrated

Always disclose:

  • All medications
  • Supplements
  • Alcohol use
  • History of pancreatitis or DKA

What You Should Do Next

If you're worried about empagliflozin, take calm, practical steps:

✅ 1. Review Your Personal Risk

Ask yourself:

  • Do I have heart disease or kidney disease?
  • Is my blood sugar difficult to control?
  • Has my doctor explained why this medication was chosen?

Understanding the reason helps reduce anxiety.


✅ 2. Monitor Smartly

If you're taking empagliflozin:

  • Check blood sugar regularly
  • Stay well hydrated
  • Avoid extreme low-carb diets unless supervised
  • Do not skip meals
  • Monitor for symptoms of infection

✅ 3. Ask Direct Questions

Bring these to your doctor:

  • Why was empagliflozin chosen for me?
  • What side effects should I personally watch for?
  • How often should labs be checked?
  • Should I hold the medication during illness?

Open communication reduces uncertainty.


✅ 4. Pause During Illness (If Advised)

Many doctors recommend temporarily stopping empagliflozin during:

  • Severe illness
  • Surgery
  • Fasting
  • Persistent vomiting

This helps reduce DKA risk.

Never stop long-term medication without medical advice—but ask about "sick day rules."


Not Sure If You're Experiencing Symptoms of Diabetes?

If you've been prescribed empagliflozin but aren't certain whether your symptoms align with Diabetes Mellitus, a free AI-powered symptom checker can help you understand what you're experiencing and prepare better questions for your next doctor's visit.


The Bottom Line on Empagliflozin

Empagliflozin is:

  • ✅ Scientifically validated
  • ✅ Recommended in major medical guidelines
  • ✅ Beneficial for heart and kidney protection
  • ✅ Generally well tolerated

But it is not risk-free.

The key is informed use, monitoring, and communication with your healthcare provider.


When to Speak to a Doctor Immediately

Seek urgent care or contact a healthcare professional right away if you experience:

  • Severe nausea or vomiting
  • Abdominal pain
  • Rapid breathing
  • Severe weakness
  • Confusion
  • Signs of serious infection
  • Chest pain
  • Severe shortness of breath

These may indicate life-threatening complications.


Final Thoughts

Being concerned about empagliflozin doesn't mean you should stop it. It means you care about your health.

The science shows real benefits—especially for people with type 2 diabetes, heart failure, or kidney disease. The risks are real but manageable with proper monitoring.

The best next step is simple:

  • Stay informed
  • Watch for symptoms
  • Stay hydrated
  • Ask questions
  • Speak to a doctor about any serious or life-threatening concerns

Good medicine is a partnership. If you're unsure, uncomfortable, or experiencing symptoms, do not ignore them. A conversation with your healthcare provider is always the safest move.

(References)

  • * Butler, J., Fonarow, G. C., Zannad, F., Filippatos, G., Pitt, B., Anker, S. D., ... & American Heart Association Council on Clinical Cardiology; Council on the Kidney in Cardiovascular Disease; and Council on Hypertension. (2022). Empagliflozin in heart failure, kidney disease and diabetes: A scientific statement from the American Heart Association. *Circulation*, *146*(9), e157-e179.

  • * Kohli, R., Majumder, S., Tuncel, M., Sunkara, B., Nimmagadda, N., Tella, S., ... & Madan, R. (2016). Safety and tolerability of empagliflozin in patients with type 2 diabetes: a comprehensive review of clinical trials. *Current Medical Research and Opinion*, *32*(6), 1109-1117.

  • * Syed, Y. Y. (2015). Empagliflozin: a review of its use in the management of type 2 diabetes mellitus. *Drugs*, *75*(17), 2059-2073.

  • * The EMPA-KIDNEY Collaborative Group. (2022). Empagliflozin for treatment of chronic kidney disease in patients with and without diabetes. *New England Journal of Medicine*, *388*(2), 117-127.

  • * Zheng, X., & Kloner, R. A. (2023). A Clinical Perspective of SGLT2 Inhibitors for Renal and Cardiovascular Disease. *Clinical Cardiology*, *46*(6), 724-733.

Thinking about asking ChatGPT?Ask me instead

Tell your friends about us.

We would love to help them too.

smily Shiba-inu looking

For First Time Users

What is Ubie’s Doctor’s Note?

We provide a database of explanations from real doctors on a range of medical topics. Get started by exploring our library of questions and topics you want to learn more about.

Learn more about diseases

Diabetes Mellitus

Was this page helpful?

Purpose and positioning of servicesUbie Doctor's Note is a service for informational purposes. The provision of information by physicians, medical professionals, etc. is not a medical treatment. If medical treatment is required, please consult your doctor or medical institution. We strive to provide reliable and accurate information, but we do not guarantee the completeness of the content. If you find any errors in the information, please contact us.